Rank #1921ETON

Eton Pharmaceuticals, Inc.

$18.22

5.87% (Daily)

Market Cap

$488.62M

Revenue

$70.32M

Rank by MCap

#1921

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Mr. Sean E. Brynjelsen

Headquarters

Deer Park, IL

Employees

About Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also devel...